These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Human telomerase inhibition by 7-deaza-2'-deoxypurine nucleoside triphosphates. Fletcher TM; Salazar M; Chen SF Biochemistry; 1996 Dec; 35(49):15611-7. PubMed ID: 8961922 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of telomerase inhibition by oxidized and therapeutic dNTPs. Sanford SL; Welfer GA; Freudenthal BD; Opresko PL Nat Commun; 2020 Oct; 11(1):5288. PubMed ID: 33082336 [TBL] [Abstract][Full Text] [Related]
9. Regulation of 5' template usage and incorporation of noncognate nucleotides by human telomerase. Moriarty TJ; Marie-Egyptienne DT; Autexier C RNA; 2005 Sep; 11(9):1448-60. PubMed ID: 16120835 [TBL] [Abstract][Full Text] [Related]
10. Effect of dGTP concentration on human and CHO telomerase. Maine IP; Chen SF; Windle B Biochemistry; 1999 Nov; 38(46):15325-32. PubMed ID: 10563818 [TBL] [Abstract][Full Text] [Related]
11. DNA-binding determinants and cellular thresholds for human telomerase repeat addition processivity. Wu RA; Tam J; Collins K EMBO J; 2017 Jul; 36(13):1908-1927. PubMed ID: 28495680 [TBL] [Abstract][Full Text] [Related]
12. Effects of nucleotide analogues on Euplotes aediculatus telomerase processivity: evidence for product-assisted translocation. Jarstfer MB; Cech TR Biochemistry; 2002 Jan; 41(1):151-61. PubMed ID: 11772012 [TBL] [Abstract][Full Text] [Related]
13. A possible mechanism of processive nucleotide and repeat additions by the telomerase. Xie P Biosystems; 2009 Sep; 97(3):168-78. PubMed ID: 19580845 [TBL] [Abstract][Full Text] [Related]
14. A modified model for translocation events of processive nucleotide and repeat additions by the recombinant telomerase. Xie P Biophys Chem; 2010 Dec; 153(1):83-96. PubMed ID: 21055868 [TBL] [Abstract][Full Text] [Related]
15. Real-time detection of human telomerase DNA synthesis by multiplexed single-molecule FRET. Hentschel J; Badstübner M; Choi J; Bagshaw CR; Lapointe CP; Wang J; Jansson LI; Puglisi JD; Stone MD Biophys J; 2023 Sep; 122(17):3447-3457. PubMed ID: 37515327 [TBL] [Abstract][Full Text] [Related]
16. Determinants in mammalian telomerase RNA that mediate enzyme processivity and cross-species incompatibility. Chen JL; Greider CW EMBO J; 2003 Jan; 22(2):304-14. PubMed ID: 12514136 [TBL] [Abstract][Full Text] [Related]
17. An anchor site-type defect in human telomerase that disrupts telomere length maintenance and cellular immortalization. Moriarty TJ; Ward RJ; Taboski MA; Autexier C Mol Biol Cell; 2005 Jul; 16(7):3152-61. PubMed ID: 15857955 [TBL] [Abstract][Full Text] [Related]
18. The Processivity of Telomerase: Insights from Kinetic Simulations and Analyses. Bagshaw CR; Hentschel J; Stone MD Molecules; 2021 Dec; 26(24):. PubMed ID: 34946615 [TBL] [Abstract][Full Text] [Related]
20. Analysis of human telomerase activity and function by two color single molecule coincidence fluorescence spectroscopy. Ren X; Li H; Clarke RW; Alves DA; Ying L; Klenerman D; Balasubramanian S J Am Chem Soc; 2006 Apr; 128(15):4992-5000. PubMed ID: 16608333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]